Country: আয়ার্লণ্ড
ভাষা: ইংরেজি
সূত্র: HPRA (Health Products Regulatory Authority)
Dimpylate
Chanelle Pharmaceuticals Manufacturing Limited
QP53AF03
Dimpylate
3.9 gram(s)/collar
Medicated collar
CAM: Companion Animal Medicine as defined in relevant national legislation
Canine
dimpylate
Ectoparasiticide
Authorised
1989-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Gullivers Flea & Tick Collar for dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per collar: ACTIVE SUBSTANCE: Dimpylate (as stabilized diazinon at 92% diazinon) 3.9 g EXCIPIENTS: Carbon black (E153) 0.004 g For a full list of excipeints, see section 6.1 3 PHARMACEUTICAL FORM Collar. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infestation of dogs with fleas (Ctenocephalides felis) and ticks (Ixodes ricinus). 4.3 CONTRAINDICATIONS Do not use in case of known hypersensitivity to the active ingredient. Do not use on sick and recovering dogs. Do not use in dogs with known liver disorder. Do not use in pregnant bitches. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None known. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _5_ _/_ _0_ _2_ _/_ _2_ _0_ _1_ _1_ _C_ _R_ _N_ _ _ _7_ _0_ _0_ _5_ _9_ _9_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE PRODUCT TO ANIMALS Due to the potential risk of hypersensitivity developing in humans to dimpylate, unnecessary handling of this product should be avoided. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) An intoxication typical for organophosphorus compounds occurs rarely. 4.7 USE DURING PREGNANCY, LACTATION OR LAY Use during pregnancy is not recommended. 4.8 INT সম্পূর্ণ নথি পড়ুন